Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Brachytherapy in craniopharyngiomas: a systematic review and meta-analysis of long-term follow-up

    Brachytherapy has been indicated as an alternative option for treating cystic craniopharyngiomas (CPs). The potential benefits of brachytherapy for CPs have not yet been clarified. The purpose of this work was...

    Li-Yuan Zhang, Wei Guo, Han-Ze Du, Hui Pan, Yun-Chuan Sun, Hui-Juan Zhu in BMC Cancer (2024)

  2. Article

    Open Access

    Tumor burden score and carcinoembryonic antigen predict outcomes in patients with intrahepatic cholangiocarcinoma following liver resection: a multi‑institutional analysis

    The prognostic significance of tumor burden score (TBS) in relation to carcinoembryonic antigen (CEA) has not been investigated among patients undergoing hepatectomy for intrahepatic cholangiocarcinoma (ICC). ...

    Jun Fu, Lifang Zheng, Shicuan Tang, Kongying Lin, Shuguo Zheng, **nyu Bi in BMC Cancer (2024)

  3. Article

    Open Access

    The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma

    Epithelioid sarcoma is a rare soft tissue sarcoma characterized by SMARCB1/INI1 deficiency. Much attention has been paid to the selective EZH2 inhibitor tazemetostat, where other systemic treatments are genera...

    Lu **e, **n Sun, Jie Xu, **n Liang, Kuisheng Liu, Kunkun Sun, Rongli Yang in BMC Cancer (2024)

  4. Article

    Open Access

    Impact of perioperative decreased serum albumin level on anastomotic leakage in esophageal squamous cell carcinoma patients treated with neoadjuvant chemotherapy followed by minimally invasive esophagectomy

    Anastomotic leakage (AL) is a severe complication following esophagectomy with high mortality. Perioperative decreased serum albumin level is considered a predictive of AL, however, its impact on AL incidence ...

    Ying-Jian Wang, **an-Feng **e, Yi-Qiu He, Tao Bao, **an-Dong He, Kun-Kun Li in BMC Cancer (2023)

  5. Article

    Open Access

    Exploratory study of an anti-PD-L1/TGF-β antibody, TQB2858, in patients with refractory or recurrent osteosarcoma and alveolar soft part sarcoma: a report from Chinese sarcoma study group (TQB2858-Ib-02)

    Novel and effective immunotherapies are required for refractory or recurrent sarcomas. Transforming growth factor-beta (TGF-β) is a diverse regulatory and fibrogenic protein expressed in multiple sarcoma tumo...

    Lu **e, **n Liang, Jie Xu, **n Sun, Kuisheng Liu, Kunkun Sun, Yuan Li in BMC Cancer (2023)

  6. Article

    Open Access

    Anatomic versus non-anatomic resection for early-stage intrahepatic cholangiocarcinoma: a propensity score matching and stabilized inverse probability of treatment weighting analysis

    Radical resection is still the most cost-effectiveness curative strategy for intrahepatic cholangiocarcinoma (ICC), but it remains controversial on the survival benefit of anatomic resection (AR). In this stud...

    Qiao Ke, Lei Wang, Ziguo Lin, Hongzhi Liu, Jianying Lou, Shuguo Zheng in BMC Cancer (2023)

  7. Article

    Open Access

    CDC50A might be a novel biomarker of epithelial ovarian cancer-initiating cells

    The aim of this work was to screen and validate biomarkers of ovarian cancer-initiating cells to detect the mechanisms of recurrence of epithelial ovarian cancer (EOC).

    Jie Yin, Yi** Wen, **g Zeng, Yanyan Zhang, Jiayu Chen, Yanmei Zhang in BMC Cancer (2022)

  8. Article

    Open Access

    Long-term outcome and relapse patterns in Ewing sarcoma patients with extensive lung/pleural metastases after a complete response to systemic therapy

    Ewing sarcoma (ES) is sensitive to systemic therapy, including chemotherapy and anti-angiogenesis Tyrosine Kinase Inhibitors(aaTKIs). However, the prognosis of patients with metastatic disease remains poor. Re...

    Jie Xu, **n Zhi, Lu **e, **n Sun, **ngyu Liu, Kuisheng Liu, Wei Guo in BMC Cancer (2022)

  9. Article

    Open Access

    Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China

    At present, hepatectomy is still the most common and effective treatment method for intrahepatic cholangiocarcinoma (ICC) patients. However, the postoperative prognosis is poor. Therefore, the prognostic facto...

    Yifan Chen, Hongzhi Liu, **yu Zhang, Yijun Wu, Wei** Zhou, Zhangjun Cheng in BMC Cancer (2021)

  10. Article

    Open Access

    Impact of surgical margin width on long-term outcomes for intrahepatic cholangiocarcinoma: a multicenter study

    The objective of this study was to investigate the survival outcomes of surgical margin width in intrahepatic cholangiocarcinoma (ICC).

    Hongzhi Liu, Lianku Lin, Ziguo Lin, Yifan Chen, Qizhen Huang, Lei Ding in BMC Cancer (2021)

  11. Article

    Open Access

    Complete remission of metastatic osteosarcoma using combined modality therapy: a retrospective analysis of unselected patients in China

    Complete surgical remission (CSR) is the best predictor of overall survival (OS) for patients with metastatic osteosarcoma. However, metastasectomy has not been widely implemented in China in the last decade d...

    Lu **e, Jie Xu, **aowei Li, Zuli Zhou, Hongqing Zhuang, **n Sun, Kuisheng Liu in BMC Cancer (2021)

  12. Article

    Open Access

    Differences in clinical characteristics and tumor prognosis between primary and secondary conventional pelvic chondrosarcoma

    Chondrosarcoma (CS) most commonly involves the pelvis. This study aimed to analyze differences in clinical characteristics and prognostic factors between primary and secondary conventional pelvic CS, and provi...

    Jie Zang, Wei Guo, Rongli Yang, **aodong Tang, Haijie Liang in BMC Cancer (2020)

  13. Article

    Open Access

    Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients

    The aim of this study was to explore the utility of circulating free DNA (cfDNA) in the evaluation of clinical tumor burden and survival in Chinese patients with metastatic colorectal cancer (mCRC) and to prel...

    **ao**g Xu, Yiyi Yu, Minna Shen, Mengling Liu, Shengchao Wu, Li Liang in BMC Cancer (2020)

  14. Article

    Open Access

    Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials

    Prostate cancer is one of the most common cancers in the world. The results of treatment after hypofractionated radiotherapy only have been reported from several small randomized clinical trials. Therefore, we...

    Wei Guo, Yun-Chuan Sun, Jian-Qiang Bi, **n-Ying He, Li **ao in BMC Cancer (2019)

  15. Article

    Open Access

    Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target

    The role of sphere-forming culture in enriching subpopulations with stem-cell properties in hepatocellular carcinoma (HCC) is unclear. The present study investigates its value in enriching cancer stem cells (C...

    **ao-Lu Ma, Yun-Fan Sun, Bei-Li Wang, Min-Na Shen, Yan Zhou, Jian-Wen Chen in BMC Cancer (2019)

  16. Article

    Open Access

    MiRNA detection in cervical exfoliated cells for missed high-grade lesions in women with LSIL/CIN1 diagnosis after colposcopy-guided biopsy

    Low-grade squamous intraepithelial lesion/cervical intraepithelial neoplasia grade 1 (LSIL/CIN1) preceded by colposcopy guided biopsy is recommended conservative follow-up, although some of these lesions are a...

    **g Ye, **ao-dong Cheng, Bei Cheng, Yi-fan Cheng, **ao-**g Chen, Wei-guo Lu in BMC Cancer (2019)

  17. Article

    Open Access

    Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using 18F-FDG PET/CT and/or routine iliac crest biopsy? A new approach of PET/CT-guided targeted bone marrow biopsy

    To investigate whether PET/CT-guided bone marrow biopsy adds complementary information for evaluation of bone marrow involvement (BMI) in newly diagnosed lymphomas.

    Bing Hao, Long Zhao, Na-na Luo, Dan Ruan, Yi-zhen Pang, Wei Guo, Hao Fu in BMC Cancer (2018)

  18. Article

    Open Access

    Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?

    The combination of gemcitabine and docetaxel (GT) has been demonstrated to be effective against various types of solid tumors, including sarcoma. However, the regimen has not been confirmed in large, well-desi...

    Jie Xu, Wei Guo, Lu **e in BMC Cancer (2018)

  19. Article

    Open Access

    PDXliver: a database of liver cancer patient derived xenograft mouse models

    Liver cancer is the second leading cause of cancer-related deaths and characterized by heterogeneity and drug resistance. Patient-derived xenograft (PDX) models have been widely used in cancer research because...

    Sheng He, Bo Hu, Chao Li, ** Lin, Wei-Guo Tang, Yun-Fan Sun in BMC Cancer (2018)

  20. Article

    Open Access

    Apatinib for advanced sarcoma: results from multiple institutions’ off-label use in China

    Anti-angiogenesis Tyrosine kinase inhibitors (TKIs) have been proved to show promising effects on prolonging progression-free survival (PFS) for advanced sarcoma after failure of standard multimodal Therapy. M...

    Lu **e, Wei Guo, Ye Wang, Taiqiang Yan, Tao Ji, Jie Xu in BMC Cancer (2018)

previous disabled Page of 2